BBH
BBH
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 14.29% | 384.39K | $52.36M |
 AMGN | Amgen Inc. | 13.90% | 151.34K | $50.92M |
 VRTX | Vertex Pharmaceuticals Incorporated | 8.08% | 66.07K | $29.60M |
 ARGX | argenx SE | 6.05% | 26.46K | $22.19M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.04% | 35.60K | $22.13M |
 IQV | IQVIA Holdings Inc. | 4.56% | 92.28K | $16.71M |
 RVMD | Revolution Medicines, Inc. | 4.55% | 107.77K | $16.66M |
 NTRA | Natera, Inc. | 4.25% | 72.85K | $15.59M |
 BIIB | Biogen Inc. | 3.98% | 74.34K | $14.60M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.78% | 45.45K | $13.86M |
 UTHR | United Therapeutics Corporation | 3.61% | 23.51K | $13.21M |
 ILMN | Illumina, Inc. | 3.21% | 74.03K | $11.75M |
 ONC | BeOne Medicines Ltd. | 3.17% | 40.03K | $11.63M |
 INSM | Insmed Incorporated | 3.04% | 102.77K | $11.14M |
 MRNA | Moderna, Inc. | 2.90% | 223.59K | $10.64M |
 INCY | Incyte Corporation | 2.33% | 87.47K | $8.53M |
 NBIX | Neurocrine Biosciences, Inc. | 2.30% | 53.83K | $8.42M |
 BNTX | BioNTech SE | 2.26% | 88.76K | $8.29M |
 ICLR | ICON Public Limited Company | 1.57% | 42.09K | $5.76M |
 CRL | Charles River Laboratories International, Inc. | 1.34% | 27.14K | $4.92M |
SECTOR HOLDINGS
Healthcare
Cash & OthersASSET ALLOCATION BY REGION
United States
Netherlands
Switzerland
Germany
IrelandSECTOR HOLDINGS
Healthcare Cash & OthersASSET ALLOCATION BY REGION
United States Netherlands Switzerland Germany IrelandHoldings (Top 20)
GILD
Gilead Sciences, Inc.
AMGN
Amgen Inc.
VRTX
Vertex Pharmaceuticals Incorporated
ARGX
argenx SE
REGN
Regeneron Pharmaceuticals, Inc.
IQV
IQVIA Holdings Inc.
RVMD
Revolution Medicines, Inc.
NTRA
Natera, Inc.
BIIB
Biogen Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
UTHR
United Therapeutics Corporation
ILMN
Illumina, Inc.
ONC
BeOne Medicines Ltd.
INSM
Insmed Incorporated
MRNA
Moderna, Inc.
INCY
Incyte Corporation
NBIX
Neurocrine Biosciences, Inc.
BNTX
BioNTech SE
ICLR
ICON Public Limited Company
CRL
Charles River Laboratories International, Inc.